Predict team wins People’s Choice Award

Professor Gordon Wishart is a finalist in the 'Rising Star' category of the LaingBuisson Health & Care Awards 2018.
December 3rd, 2018|Breast Cancer, Check4Cancer, Health Investor Awards 2018, Predict|

Finalist in the “Rising Star” category

Professor Gordon Wishart is a finalist in the 'Rising Star' category of the LaingBuisson Health & Care Awards 2018.
December 3rd, 2018|Breast Cancer, Check4Cancer, Health Investor Awards 2018|

Check4Cancer wins ‘Diagnostics provider of the year’ at the 2018 Health Investor Awards

London, UK, 15th June 2018 / Check4Cancer has been awarded ...
June 22nd, 2018|Breast Cancer, Check4Cancer, Health Investor Awards 2018|

AvMA Annual Clinical Negligence Conference

Professor Gordon Wishart, Check4Cancer’s Chief Medical Officer has been...
May 5th, 2018|Breast Cancer, Check4Cancer|

Association of Breast Surgery Conference June 2018

Professor Gordon Wishart, Check4Cancer’s Chief Medical Officer is delighted to announce...
February 11th, 2018|Breast Cancer, Check4Cancer|

Health Investor Awards 2018

Professor Gordon Wishart, Check4Cancer’s Chief Medical Officer is delighted...
February 10th, 2018|Breast Cancer, Check4Cancer|

Predict breast cancer survival model reaches special landmark

Predict breast cancer survival model (www.predict.nhs.uk) reaches special landmark...
April 3rd, 2017|Breast Cancer, Predict|

American Joint Committee on Cancer

In November 2016, The PREDICT survival model (www.predict.nhs.uk) was one of only two breast cancer prognostic models out of 30 reviewed...
November 25th, 2016|Breast Cancer|

XX Russian Oncology Congress

On 17 November 2016, Professor Gordon Wishart gave an invited presentation on “Sentinel node biopsy in early breast cancer” at the XX Russian Oncology Conference in Moscow.
November 25th, 2016|Breast Cancer|

Proof of Causation

Until now, proof of causation in cases of breast cancer delay has relied on being able to show that a delay in treatment has reduced the prospects of 10-year survival from above 50% to below 50%.
June 27th, 2014|Breast Cancer|